arrow
Back
H

Heinz Schmidli

Novartis

35H-index
109Paper Count
3.9KCitation Count
Published Papers 16
Publication Date
Estimands-What they are and why they are important for pharmacometricians
err2021-05-03
err13
errOAAI
errAkacha, Mouna; Bartels, Christian; Bornkamp, Bjorn; Bretz, Frank; Coello, Neva; Dumortier, Thomas; Looby, Michael; Sander, Oliver; Schmidli, Heinz; Steimer, Jean-Louis; Vong, Camille
errShare
errSave
Applying Meta-Analytic-Predictive Priors with the R Bayesian Evidence Synthesis Tools
err2021-01-01
err24
errOAAI
errWeber, Sebastian; Li, Yue; Seaman, John W., III; Kakizume, Tomoyuki; Schmidli, Heinz
errShare
errSave
Beyond Randomized Clinical Trials: Use of External Controls
err2019-12-17
err84
PREAI
errSchmidli, Heinz; Haring, Dieter A.; Thomas, Marius; Cassidy, Adrian; Weber, Sebastian; Bretz, Frank
errShare
errSave
Trends in annualized relapse rates in relapsing-remitting multiple sclerosis and consequences for clinical trial design
err2017-05-16
err44
errOAAI
errNicholas, Richard; Straube, Sebastian; Schmidli, Heinz; Schneider, Simon; Friede, Tim
errShare
errSave
The Effects of a Flexible Visual Acuity-Driven Ranibizumab Treatment Regimen in Age-Related Macular Degeneration: Outcomes of a Drug and Disease Model
err2010-01-01
err66
errOAAI
errHolz, Frank G.; Korobelnik, Jean-Francois; Lanzetta, Paolo; Mitchell, Paul; Schmidt-Erfurth, Ursula; Wolf, Sebastian; Markabi, Sabri; Schmidli, Heinz; Weichselberger, Andreas
errShare
errSave
Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimer's disease patients
err2007-05-23
err109
errOAAI
errLefevre, G.; Sedek, G.; Jhee, S. S.; Leibowitz, M. T.; Huang, H-LA; Enz, A.; Maton, S.; Ereshefsky, L.; Pommier, F.; Schmidli, H.; Appel-Dingemanse, S.
errShare
errSave
Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12-and 36-month results
err2006-11-01
err109
errOAAI
errLevy, Gary; Schmidli, Heinz; Punch, Jeffrey; Tuttle-Newhall, Elizabeth; Mayer, David; Neuhaus, Peter; Samuel, Didier; Nashan, Bjorn; Klempnauer, Juergen; Langnas, Alan; Calmus, Yvon; Rogiers, Xavier; Abecassis, Michael; Freeman, Richard; Sloof, Maarten; Roberts, John; Fischer, Lutz
errShare
errSave
Everolimus in pulmonary transplantation: Pharmacokinetics and exposure-response relationships
err2006-04-01
err31
PREAI
errKovarik, JM; Snell, GI; Valentine, V; Aris, R; Chan, CKN; Schmidli, H; Pirron, U
errShare
errSave
Population pharmacokinetics of imatinib mesylate in patients with chronic-phase chronic myeloid leukaemia: results of a phase III study
err2005-03-02
err114
errOAAI
errSchmidli, H; Peng, B; Riviere, GJ; Capdeville, R; Hensley, M; Gathmann, I; Bolton, AE; Racine-Poon, A
errShare
errSave
Therapeutic drug monitoring for everolimus in heart transplant recipients based on exposure-effect modeling
err2004-12-01
err72
errOAAI
errStarling, RC; Hare, JM; Hauptman, P; McCurry, KR; Mayer, HW; Kovarik, JM; Schmidli, H
errShare
errSave